Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - GROSS PROFIT
Gross Profit APLS - Apellis Pharmaceuticals, Inc.
338 M
LAST VALUE
134.72%
2 YEAR CAGR
35.94%
5 YEAR CAGR
0.00%
10 YEAR CAGR